BusinessWeek Logo
November 23, 2009 6:29 PM ET

Meridian Bioscience Inc.

(VIVO:NASDAQ)

LAST $20.81 USD
CHANGE TODAY -0.04 -0.19%
VOLUME 377.9K
As of 4:00 PM 11/23/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Meridian Bioscience Inc. (VIVO)

OPEN
$21.14
PREVIOUS CLOSE
$20.85
DAY HIGH
$21.25
DAY LOW
$20.34
52 WEEK HIGH
01/5/09 - $26.41
52 WEEK LOW
04/16/09 - $14.79
MARKET CAP
843.2M
AVERAGE VOLUME 3 mo
231.4K
DILUTED EPS TTM
$0.80
SHARES OUTSTANDING
40.5M
EX-DATE
11/19/09
P/E TTM
26.0x
DIVIDEND
$0.68
DIVIDEND YIELD
3.27%
K = Thousands  M = Millions  B = Billions

VIVO Details

Meridian Bioscience Inc., an integrated life science company, manufactures, develops, sells, and distributes diagnostic test kits. These are used primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases. It also makes and distributes bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers. In addition, it contract-manufactures proteins and other biologicals for biopharmaceutical and biotechnology companies researching new drugs and vaccines. Its products and technologies are marketed to hospitals, reference labs, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in about 60 countries. Meridian, founded in 1976, is based in Cincinnati.

VIVO Top Compensated Officers

Chief Executive Officer and Director
Age: 61
Total Annual Compensation: $628.7K
Founder and Executive Chairman
Age: 68
Total Annual Compensation: $716.5K
Chief Financial Officer, Vice President and S...
Age: 46
Total Annual Compensation: $278.9K
Executive Vice President of Operations and In...
Age: 50
Total Annual Compensation: $309.0K
Senior Vice President, President of Meridian ...
Age: 59
Total Annual Compensation: $539.2K
Compensation as of Fiscal Year 2008.

Key developments for Meridian Bioscience Inc. (VIVO)

Meridian Bioscience Inc. expected to Report Q1 2010 Results on January 18, 2010. This event was calculated by Capital IQ (Created on November 13, 2009).

Meridian Bioscience Inc. expected to Report Q1 2010 Results on January 18, 2010. This event was calculated by Capital IQ (Created on November 13, 2009).

Meridian Bioscience Inc. expected to Report Fiscal Year 2009 Results on November 12, 2009. This event was calculated by Capital IQ (Created on October 30, 2009).

Meridian Bioscience Inc. expected to Report Fiscal Year 2009 Results on November 12, 2009. This event was calculated by Capital IQ (Created on October 30, 2009).

Hospitals, Healthcare Providers to Save with New Premier Agreements for Rapid Diagnostic Test Kits with Meridian Bioscience and OraSure

Premier Purchasing Partners, LP announced new agreements for rapid diagnostic test kits have been awarded to Meridian Bioscience Corporation of Cincinnati and OraSure Technologies Inc. of Bethlehem, Pa., a small business enterprise. Effective November 1, 2009, the agreements are available to acute care and continuum of care members of the Premier healthcare alliance.

BusinessWeek Rankings

Hot Growth 100
2007  #68
2005  #86

Stock Quotes

Company Lookup
Recently Viewed
VIVO $20.81 USD -0.04
KCI $33.89 USD +0.53
AMED $38.97 USD +1.28
FWRD $23.99 USD +0.57
GW (CA) C$9.93 CAD +0.03

Market data is delayed at least 20 minutes.

VIVO Competitors

Company Last Change
Immucor Inc $19.21 USD +0.44
Neogen Corp $33.68 USD +0.47
OraSure Tech Inc $4.28 USD +0.13
Quidel Corp $13.21 USD -0.02
Trinity Biotech PLC $4.05 USD -0.02
View Industry Companies
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation VIVO Industry Range
Price/Earnings 26.2x
Price/Sales 5.7x
Price/Book 6.3x
Price/Cash Flow 25.8x
TEV/Sales 5.3x

VIVO

 | 

VIVO transactions

Type
Date
Target
No transactions in the last 6 months.

Companies Toolbox

Company Tools
Investing Tools

SEARCH FOR JOBS

Post a Job
See all Job Listings

Jobs by SimplyHired



Close Recommend A Data Enhancement Or Correction

For Meridian Bioscience Inc. (VIVO) Snapshot

Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.

Required Information Missing - Please enter your information in the following field(s):
DATA TO BE REVIEWED
Page Section*

Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.

Data Point*

Please indicate which data is in error.

CONTACT INFORMATION

Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.

Your Name*
Your E-Mail Address*
YOUR RECOMMENDATION

Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.

Cancel Submit
You can drag this form within your browser window.

Thank you for submitting your information. We investigate data update requests and error reports as quickly as possible. Since some are easier to investigate than others, please be patient as we perform our research; it could take several weeks, depending on the nature of the error and whether your company is public or private.

You can drag this form within your browser window.